Insights

Early phase acceleration CARBOGEN AMCIS has launched SPRINT, a dedicated early-phase drug substance development approach designed to accelerate progression to clinical phases without compromising scientific rigour. This presents an opportunity to engage biotech and pharma clients seeking faster timelines for IND-enabling studies and early-phase CMC support.

ADC expertise The company operates dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates, and recently announced strategic partnerships to offer integrated ADC development and manufacturing solutions. This positions them well to win business from biopharma firms pursuing complex ADC programs requiring end-to-end CDMO capabilities.

Regulatory strength Recent GMP and ANSM certifications for multiple sites reinforce reliability and compliance in manufacturing. Target customers prioritizing robust quality systems and regulatory readiness can be approached for ongoing and new substance and product manufacturing engagements.

Global partnerships Strategic collaborations, including a planned integrated ADC solution with Celonic Group, indicate a growth strategy focused on broadening biologics and conjugation capabilities. This suggests cross-selling opportunities with biologics players and those seeking integrated CDMO ecosystems.

Diversified capabilities Beyond complex modalities, CARBOGEN AMCIS offers cholesterol and vitamin D analogs and a broad portfolio of process development and API manufacturing services in a fully cGMP infrastructure. This diversification can be leveraged to upsell additional services or win multi-site, multi-portfolio programs from existing customers.

Similar companies to CARBOGEN AMCIS

CARBOGEN AMCIS Tech Stack

CARBOGEN AMCIS uses 8 technology products and services including LinkedIn Ads, Hotjar, Power BI, and more. Explore CARBOGEN AMCIS's tech stack below.

Media & News

CARBOGEN AMCIS's Email Address Formats

CARBOGEN AMCIS uses at least 3 email formats:
CARBOGEN AMCIS Email FormatsExamplePercentage
First.Last@carbogen-amcis.comJohn.Doe@carbogen-amcis.com
98%
First.Middle@carbogen-amcis.comJohn.Michael@carbogen-amcis.com
1%
First.MiddleLast@carbogen-amcis.comJohn.MichaelDoe@carbogen-amcis.com
1%

Frequently Asked Questions

What is CARBOGEN AMCIS's phone number?

Minus sign iconPlus sign icon
You can contact CARBOGEN AMCIS's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CARBOGEN AMCIS's official website and social media links?

Minus sign iconPlus sign icon
CARBOGEN AMCIS's official website is carbogen-amcis.com and has social profiles on LinkedIn.

How much revenue does CARBOGEN AMCIS generate?

Minus sign iconPlus sign icon
As of October 2026, CARBOGEN AMCIS's annual revenue is estimated to be $50M - $100M.

What is CARBOGEN AMCIS's NAICS code?

Minus sign iconPlus sign icon
CARBOGEN AMCIS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does CARBOGEN AMCIS have currently?

Minus sign iconPlus sign icon
As of October 2026, CARBOGEN AMCIS has approximately 728 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Business Officer: F. B., Chief Quality & Compliance Officer: M. S. and Chief Quality & Compliance Officer: M. S. Explore CARBOGEN AMCIS's employee directory with LeadIQ.

What industry does CARBOGEN AMCIS belong to?

Minus sign iconPlus sign icon
CARBOGEN AMCIS operates in the Pharmaceutical Manufacturing industry.

What technology does CARBOGEN AMCIS use?

Minus sign iconPlus sign icon
CARBOGEN AMCIS's tech stack includes LinkedIn Ads, Hotjar, Power BI, AutoCAD, Joomla, SuccessFactors, Office 365 and Piwik PRO Core.

What is CARBOGEN AMCIS's email format?

Minus sign iconPlus sign icon
CARBOGEN AMCIS's email format typically follows the pattern of First.Last@carbogen-amcis.com. Find more CARBOGEN AMCIS email formats with LeadIQ.
CARBOGEN AMCIS logo

CARBOGEN AMCIS

Pharmaceutical ManufacturingBasel-Landschaft, Switzerland501-1000 Employees

CARBOGEN AMCIS is a pharmaceutical manufacturing company based at 171 Hauptstrasse, Bubendorf, Basel-Landschaft 4416, Switzerland, employing 501-1000 people. The firm provides drug substance and drug product development and commercialization services for pharmaceutical and biopharmaceutical companies. Its operations run in a fully cGMP-compliant infrastructure that includes dedicated highly potent API facilities and a clean room for Antibody Drug Conjugates. In addition to development and manufacturing services, CARBOGEN AMCIS supplies cholesterol and vitamin D analogs. The company is owned by Dishman Carbogen Amcis Limited, based in India.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $50M - $100M

    CARBOGEN AMCIS's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.